Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 314

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Implantable Cardioverter Defibrillator in High‐Risk Long QT Syndrome Patients

ZAREBA, WOJCIECH, MOSS, ARTHUR J., DAUBERT, JAMES P., HALL, W. JACKSON, ROBINSON, JENNIFER L., ANDREWS, MARK · 2003 · Journal of Cardiovascular Electrophysiology

Abstract

Introduction: Implantable cardioverter defibrillators (ICDs) are increasingly being used in high‐risk long QT syndrome (LQTS) patients, but there are limited data regarding clinical experience with this therapeutic modality. The aim of this study is to describe the clinical characteristics of 125 LQTS patients treated with ICDs compared with LQTS patients having similar risk indications who were not treated with ICDs. Methods and Results: Among 125 LQTS patients with ICDs, there were 54 cardiac arrest survivors, 19 patients who had ICDs implanted due to recurrent syncope despite beta‐blocker therapy, and 52 patients with ICDs implanted due to other reasons, including syncope and LQTS‐related sudden death in a close family member. Patients with cardiac arrest and those with recurrent syncope despite beta‐blocker therapy (n = 73) were compared to 161 LQTS patients who had similar indications (89 cardiac arrest and 72 recurrent syncope despite beta‐blocker therapy) but did not receive ICDs. Total mortality was the endpoint of the analysis. There was 1 (1.3%) death in 73 ICD patients followed an average of 3 years, whereas there were 26 deaths (16%) in non‐ICD patients during mean 8‐year follow‐up (P = 0.07 from log rank test from Kaplan‐Meier curves). Conclusion: ICDs provide an important therapeutic option to prevent sudden arrhythmic death in high‐risk LQTS patients. A long‐term prospective study is needed to determine the benefit of this therapeutic modality in LQTS patients. (J Cardiovasc Electrophysiol, Vol. 14, pp. 337‐341, April 2003)

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1540-8167.2003.02545.x

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 19 references

Cited by

See all 314

Metadata

Authors
ZAREBA, W., MOSS, A. J., DAUBERT, J. P., HALL, W. J., ROBINSON, J. L., & ANDREWS, M.
Venue
Journal of Cardiovascular Electrophysiology
Publisher
Wiley
Published
2003-04
Volume
14
Issue
4
Pages
337-341
ISSN
  • 1045-3873 (ISSN-L)
  • 1540-8167
OpenAlex
W2159701763
Cited by
314
References
19
FWCI
14.25
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Implantable Cardioverter Defibrillator in High‐Risk Long QT Syndrome Patients. https://app.cochat.ai/papers/10.1046/j.1540-8167.2003.02545.x
The paper
ZAREBA, W., MOSS, A. J., DAUBERT, J. P., HALL, W. J., ROBINSON, J. L., & ANDREWS, M. (2003). Implantable Cardioverter Defibrillator in High‐Risk Long QT Syndrome Patients. Journal of Cardiovascular Electrophysiology. https://doi.org/10.1046/j.1540-8167.2003.02545.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.